Skip to content

Thailand logo

Main menu
      • Vision, mission and values
Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:

Our vision, mission & values

We believe that women are foundational to a healthier world.

วิสัยทัศน์

สุขภาวะที่ดีขึ้นทุกวันสำหรับผู้หญิงทุกคน

ความมุ่งมั่น

เรามีความมุ่งมั่นว่าเราจะสามารถส่งมอบยาและผลิตภัณฑ์ต่างๆ ที่จะทำให้เธอได้ใช้ชีวิตด้วยสุขภาพที่ดีขึ้นในทุกวัน

Icons / 16 / PlayButton Created with Sketch.
youtube
https://www.youtube.com/watch?v=0sd20KIWSeU
:https://www.youtube.com/watch?v=0sd20KIWSeU

สุขภาพของเธอ คือทุกวันของเรา

และนี่คือเหตุผลว่าทำไมเราถึงให้ความสำคัญในการสร้างสุขภาวะที่ดีขึ้นทุกวันสำหรับผู้หญิงทุกคน

ค่านิยมของเรา

พนักงานของเราให้คำสัญญากับออร์กานอน และตั้งใจทำให้มันเกิดขึ้นจริง จากการเรียกร้องในสิ่งที่มันขาดหายไปในโลกใบนี้ โดยเราจะกระทำการต่างๆอย่างซื่อสัตย์ เพราะพวกเราคือรากฐานขององค์กรในการขับเคลื่อนค่านิยม และทำสิ่งต่างๆให้เกิดขึ้นจริง

Be real

Be real

Be real

เราทำงานด้วยความโปร่งใสและจริงใจ

Own it

Own it

Own it

เราผลักดันการสร้างความไว้วางใจและมอบอำนาจการตัดสินใจที่มาพร้อมกับความซื่อสัตย์และมาตรฐานทางจริยธรรม

Rise together

Rise together

Rise together

เราร่วมมือกันเพื่อความสำเร็จร่วมกันของทีม

Keep moving

Keep moving

Keep moving

เรามีหัวใจของผู้ประกอบการ ยืดหยุ่น ไม่หวั่นกับความท้าทาย และยอมรับการเปลี่ยนแปลง

Bring your fire

Bring your fire

Bring your fire

เรามีความมุ่งมั่นในวิสัยทัศน์ ไม่ย่อท้อที่จะทำทุกวิถีทางเพื่อให้บรรลุเป้าหมาย

We all belong

We all belong

We all belong

เราให้ความสำคัญกับความหลากหลายในทุกสิ่งที่ทำ เพื่อให้ทุกคนได้แสดงความคิดเห็นและรู้สึกมีส่วนร่วม

Be realhttps://www.organon.com/wp-content/uploads/sites/2/2021/04/Be-Real-V2-e1617375312339.png

Code of conduct & compliance

Our code of conduct details our ethical and business standards and practices.

Code of conduct

Our code of conduct represents the very core of our company’s character by providing guidance on business standards and practices and helping our employees understand what is expected of them.

View COC

Our business partner code of conduct

We strive to treat all of our business partners honestly, fairly and with respect.

Business partner COC Supplier performance expectations

About our compliance program

Being an ethical company is about much more than simply adhering to the letter of the law. But it’s an important step.

As part of our commitment to ethics and good corporate citizenship, our first step is always to comply with the laws and regulations that govern the way we market and sell our medicines and other healthcare products.

We have a compliance program that:

  • is consistent with recommendations set forth by the U.S. Department of Health and Human Services and the Code on Interactions with Healthcare Professionals created by the Pharmaceutical Research and Manufacturers of America (PhRMA);
  • seeks to prevent, detect and resolve potential violations of law or company policy; and
  • undergoes regular assessment and adjustment to make sure we are being responsive to our evolving business and associated compliance risks.

Our board of directors and senior management, including the company’s chief ethics and compliance officer, oversee the company’s global compliance program, including compliance-related policies, procedures, education and training.

In addition, we:

  • require employees to report potential violations of law or company policy;
  • hold ourselves accountable for responding promptly when potential violations arise;
  • take disciplinary action as appropriate; and
  • examine whether identified violations are in part due to gaps in our policies, practices or internal controls and, if so, take appropriate action to prevent future violations.

Learn more about our compliance

See our comprehensive compliance program document

Thailand logo
  • Forward-Looking Statement
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept